Although Vγ9Vδ2 T cells derived from human PBMCs demonstrated good cytotoxicity against gliomas that overexpress BTN2A1/BTN3A1, such overexpression occurred in less than 30% of GBM cases. This evidence concerns the gene BTN3A1 and glioblastoma.